| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MARKET VECTORS PHARMACEUTICAL | 6,500 | 460,000 | 0.04% | ||
| 2 | CELLDEX THERAPEUTICS INC NEW | 32,765 | 826,000 | 0.07% | ||
| 3 | ISHARES TRUST US HLTHCR PR ETF | 8,599 | 1,229,000 | 0.10% | ||
| 4 | ADURO BIOTECH INC | 61,639 | 1,870,000 | 0.15% | ||
| 5 | INVITAE CORP | 181,224 | 2,563,000 | 0.21% | ||
| 6 | Axovant Sciences LTD | 150,000 | 3,057,000 | 0.25% | ||
| 7 | FLEXION THERAPEUTICS INC | 142,483 | 3,119,000 | 0.26% | ||
| 8 | ELEVEN BIOTHERAPEUTICS INC | 1,261,260 | 3,557,000 | 0.29% | ||
| 9 | CHEMOCENTRYX INC | 476,293 | 3,920,000 | 0.32% | ||
| 10 | ARRAY BIOPHARMA INC 3 06/01/2020 | 4,000,000 | 5,050,000 | 0.41% | PRN | |
| 11 | BELLICUM PHARMACEUTICALS INCORPORATED | 238,121 | 5,065,000 | 0.42% | ||
| 12 | ULTRAGENYX PHARMACEUTICAL INC COM | 67,425 | 6,904,000 | 0.57% | ||
| 13 | PORTOLA PHARMACEUTICALS INC | 152,700 | 6,955,000 | 0.57% | ||
| 14 | TRIVASCULAR TECHNOLOGIES INC | 1,464,563 | 7,835,000 | 0.64% | ||
| 15 | CERUS CORP | 1,603,427 | 8,322,000 | 0.68% | ||
| 16 | FLUIDIGM CORP DEL COM | 348,237 | 8,427,000 | 0.69% | ||
| 17 | GENOCEA BIOSCIENCES INC | 623,519 | 8,561,000 | 0.70% | ||
| 18 | ProQR Therapeutics NV | 516,690 | 8,613,000 | 0.71% | ||
| 19 | AVALANCHE BIOTECHNOLOGIES IN | 537,282 | 8,725,000 | 0.72% | ||
| 20 | BLUEPRINT MEDICINES CORP COM | 378,235 | 9,671,000 | 0.79% | ||
| 21 | DAVITA INC | 140,191 | 11,141,000 | 0.91% | ||
| 22 | FATE THERAPEUTICS INC | 2,007,446 | 12,988,000 | 1.06% | ||
| 23 | CIVITAS SOLUTIONS INC | 657,693 | 14,029,000 | 1.15% | ||
| 24 | ONCOTHYREON INC COM N/C EFF 6/ | 4,164,878 | 15,577,000 | 1.28% | ||
| 25 | ZS PHARMA INC | 302,988 | 15,874,000 | 1.30% | ||
| 26 | CASTLIGHT HEALTH INC COM CL B | 1,984,631 | 16,155,000 | 1.32% | ||
| 27 | Oxford Immunotec Global PLC | 1,212,892 | 16,799,000 | 1.38% | ||
| 28 | MODEL N INCORPORATED | 1,443,278 | 17,189,000 | 1.41% | ||
| 29 | INCYTE CORP | 164,995 | 17,194,000 | 1.41% | ||
| 30 | GW PHARMACEUTICALS PLC | 146,027 | 17,938,000 | 1.47% | ||
| 31 | INTRA-CELLULAR THERAPIES INC | 610,171 | 19,495,000 | 1.60% | ||
| 32 | Atara Biotherapeutics Inc | 372,642 | 19,661,000 | 1.61% | ||
| 33 | INSMED INC | 867,346 | 21,181,000 | 1.74% | ||
| 34 | SAGE THERAPEUTICS INC | 290,350 | 21,196,000 | 1.74% | ||
| 35 | NANOSTRING TECHNOLOGIES INC | 1,459,742 | 22,509,000 | 1.84% | ||
| 36 | ALERE INC | 461,170 | 24,327,000 | 1.99% | ||
| 37 | HEALTH NET INC | 388,128 | 24,887,000 | 2.04% | ||
| 38 | UNIVERSAL HLTH SVCS INC | 175,965 | 25,005,000 | 2.05% | ||
| 39 | SEATTLE GENETICS INC | 529,199 | 25,613,000 | 2.10% | ||
| 40 | JAZZ PHARMACEUTICALS PLC | 150,866 | 26,563,000 | 2.18% | ||
| 41 | Receptos Inc | 144,205 | 27,406,000 | 2.25% | ||
| 42 | BIOMARIN PHARMACEUTICAL INC | 207,744 | 28,415,000 | 2.33% | ||
| 43 | BIOGEN INC | 79,118 | 31,959,000 | 2.62% | ||
| 44 | CIGNA CORPORATION | 198,700 | 32,189,000 | 2.64% | ||
| 45 | CHIMERIX INC | 699,425 | 32,313,000 | 2.65% | ||
| 46 | AETNA INC NEW | 264,075 | 33,659,000 | 2.76% | ||
| 47 | ABBVIE INC | 510,010 | 34,268,000 | 2.81% | ||
| 48 | HCA HOLDINGS INC | 390,000 | 35,381,000 | 2.90% | ||
| 49 | KYTHERA BIOPHARMACEUTICALS I | 482,556 | 36,341,000 | 2.98% | ||
| 50 | ALLERGAN PLC | 136,818 | 41,519,000 | 3.40% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-15-000017, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
